Immunolabeling of key biomarkers, such as prostate-specific membrane antigen (PSMA), prostate stem cell antigen (PSCA), and epithelial–mesenchymal transition (EMT)-related proteins, has demonstrated strong correlations with the tumor grade and stage [42,45,69]. Here, FOLH1 is linked to neoplasm.